Skip to main content

Estrogen-Linked Thrombotic Biomarkers Drop After Cessation of Combo Pill

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 15, 2023.

By Elana Gotkine HealthDay Reporter

TUESDAY, Nov. 14, 2023 -- Cessation of combined hormonal contraceptives (CHC) is associated with a rapid decline in estrogen-related thrombotic biomarkers, according to a study published online Nov. 8 in Blood.

Justine Hugon-Rodin, M.D., Ph.D., from the Hospital Saint Joseph in Paris, and colleagues conducted a prospective cohort study to define the time until normalization of the estrogen-related thrombotic biomarkers after CHC cessation. Women aged 18 to 50 years who had decided to stop their CHC were enrolled. The study started six weeks before CHC cessation and included six visits afterward up to 12 weeks after cessation.

The researchers found that from baseline to week 12, there were decreases in the average levels of normalized sensitivity ratios to activated protein C (4.11 to 1.27 nmol/L), thrombomodulin (2.53 to 1.11 nmol/L), and sex hormone-binding globulin (167 to 55.4 nmol/L) among 66 users of CHC. Overall, 85.8, 81.3, and 76.2 percent and 86.7, 85.5, and 87.8 percent of the decrease from baseline to week 12 was achieved at two and four weeks after CHC cessation, respectively. Among 28 control women, levels were not meaningfully modified throughout the study.

"It's reassuring to know that that possible harm of the pill goes away rapidly when one stops taking it," coauthor Marc Blondon, M.D., from the University Hospitals of Geneva, said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted November 2023

Read this next

Decrease in Oral Contraceptive Fills Seen After Dobbs Ruling

WEDNESDAY, June 26, 2024 -- The Dobbs v Jackson Women's Health Organization decision, allowing states to strengthen restrictions on abortion access, was associated with declines...

ENDO: Novel Male Contraceptive Gel May Achieve Faster Sperm Suppression

WEDNESDAY, June 12, 2024 -- A novel male contraceptive gel suppresses sperm production faster than other hormone-based methods for male birth control, according to a phase 2 study...

AAN Issues Guideline for Use of Antiseizure Meds in People of Childbearing Potential

FRIDAY, May 17, 2024 -- In a practice guideline issued by the American Academy of Neurology, along with the American Epilepsy Society and the Society for Maternal-Fetal Medicine...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.